Genevieve
Lemarchal

Suncoast Ventures started the way most great things do - not with a pitch deck, not with a term sheet, but with an idea scribbled on a napkin in July 2021. That napkin is now a portfolio spanning three dozen healthcare companies on four continents, most of them doing work that larger, more cautious funds decided was not worth the risk.

Genevieve Lemarchal is the kind of investor who reads the term sheets herself, answers emails from first-time founders, and can explain why FDA-cleared fetal monitoring matters to a Medicaid population in the same breath. She arrived at venture through the side door: serial entrepreneur, Pacific Northwest native, University of Washington MBA, Washington State University communications degree. She built companies across tech, ecommerce, nonprofits, and social enterprises before she ever wrote a check.

That founder background is not incidental - it is the entire point. Lemarchal spent years watching how capital moves, or refuses to move, toward certain kinds of founders. She co-founded XXcelerate Fund in 2017, a revolving loan fund for women-owned startups, before the term "founder-friendly VC" became a marketing slogan. She spent four years at FoundersPad VC Fund II in Oregon learning the machinery of early-stage investing. When she launched Suncoast, she had a specific thesis already road-tested: back healthcare founders addressing the gaps that the system actively ignores.

The gaps Suncoast targets are not obscure academic problems. Addiction recovery. High-risk pregnancies. Chronic disease management for Medicaid populations. Digital diagnostics for communities where the nearest hospital is 90 minutes away. These are markets that are simultaneously enormous and systematically underfunded - not because they lack demand, but because the traditional VC mental model equates "difficult customer" with "bad investment."

Lemarchal inverts that logic. Her portfolio company Sober Sidekick built an "empathy algorithm" to connect people in addiction recovery - 24 hours a day, without a clinical intake form. BloomLife built a wearable for high-risk pregnancy monitoring that can flag complications before they become emergencies. MDisrupt built infrastructure for digital health and medtech companies trying to navigate the labyrinthine path from product to patient. Each company addresses a problem that anyone paying attention already knew existed.

In 2022, Crunchbase named Lemarchal among the most prolific early-stage investors in Southern California. The same year, Biocom California awarded her the Lifescience Catalyst Award - a recognition from the industry's own infrastructure that the work was landing. Neither honor slowed her down. She was already building the next layer.

In 2023, she added Head of Healthcare at Expert Dojo to her portfolio - a role that puts her at the center of Southern California's most active growth accelerator and pre-seed fund. Expert Dojo is the third most active in the United States. The role means Lemarchal is now evaluating, mentoring, and backing healthcare founders at two distinct organizational levels simultaneously.

She also runs the AdVentureous Podcast - a biweekly show where she talks to entrepreneurs and VCs about the work of building things that matter. The name is exactly what it sounds like: a portmanteau of adventure and ventures, which is also a decent description of how she approaches the job. Tim Draper, one of the most recognized names in Silicon Valley, showed up to talk about family, values, and legacy. That is not a conversation most emerging managers can schedule.

There is a statistic Lemarchal returns to often: less than 2% of venture capital goes to women. She does not treat this as background information. She treats it as a design problem - one with known variables, addressable causes, and a portfolio that constitutes a running counterargument. Fifty percent of Suncoast's portfolio companies are women-founded. Thirty-seven to forty-three percent come from underrepresented backgrounds. Those numbers do not happen by accident. They happen by explicit decision, repeated across every deal.

She has logged more than 10,000 hours mentoring founders in early-stage sales, marketing, and growth strategy. She has worked with more than 1,000 founders. She delivers keynotes globally. The question is not what Genevieve Lemarchal is doing - it is how she fits it all in a calendar.

The AdVentureous Podcast episode title that appeared on Michael Knouse's show - "From Stressed and Broke to Triple Digit Growth" - is the kind of headline Lemarchal tends to lean into rather than away from. The origin story she carries is not a polished LinkedIn biography. It is the messier version: multiple companies, a revolving fund she built before the infrastructure existed to support it, a VC career that started in Oregon and eventually landed in a firm she had to create herself to make the investments she wanted to make.

She writes on Medium about healthcare, women in business, entrepreneurship, AI, and philosophy. She has 1,860+ posts on Instagram - a number that reflects the same consistency she talks about with founders: show up every day, even when it is unglamorous. She currently divides her time between the San Francisco Bay Area and San Diego, which means she is simultaneously embedded in two of the country's most active healthcare and technology ecosystems.

The napkin from July 2021 has been through a few revisions by now. The underlying idea has not.